Non-invasive determination of fetal inheritance of parental haplotypes at the genome-wide scale
View Patent ↗The present invention provides a method, device and a computer program for haplotyping single cells, such that a sample taken from a pregnant female, without directly sampling the fetus, provides the ability to non-invasively determine the fetal genome. The method can be performed by determining the parental and inherited haplotypes, or can be performed merely on the basis of the mother's genetic information, obtained preferably in a blood or serum sample. The novel device allows for sequence analysis of single chromosomes from a single cell, preferably by partitioning single chromosomes from a metaphase cell into long, thin channels where a sequence analysis can be performed.
1. A method of non-invasively determining parental haplotypes which are inherited by a fetus, comprising:
a. obtaining a maternal sample from a female pregnant with at least one fetus, wherein said sample contains DNA from both the pregnant female and the fetus;
b. determining a paternally inherited haplotype by the steps of:
i. simultaneously isolating all of the chromosomes from a single metaphase cell of the fetus's father by partitioning said chromosomes into a plurality of channels of a microfluidic device and analyzing each of said chromosomes to determine a set of paternal single nucleotide polymorphisms (SNPs);
ii. simultaneously isolating all of the chromosomes from a single metaphase cell of the fetus's mother by partitioning said chromosomes into a plurality of channels of a microfluidic device and analyzing each of said chromosomes to determine a set of maternal single nucleotide polymorphisms (SNPs);
iii. determining all SNPs that are heterozygous in the father and homozygous in the mother to identify at various loci alleles present in the father and absent in the mother, thereby defining each of the father's haplotypes; and
iv. counting a number of representative alleles on each paternal haplotype to determine a representation of the two paternal haplotypes in the maternal sample containing DNA from the pregnant female and the fetus;
v. comparing the representation of the two paternal haplotypes to obtain a relative representation in the maternal sample containing DNA from the pregnant female and the fetus;
vi. determining an over-representation ε of one of the two paternal haplotypes in the maternal sample containing DNA from the pregnant female and the fetus; and
vii. correlating said over-representation ε with a paternally inherited haplotype; and
c. determining a maternally inherited haplotype by the steps of:
i. determining all SNPs that are heterozygous in the fetus's mother; and
ii. identifying alleles present in the mother but absent in the paternally inherited haplotype at each SNP locus to define the mother's haplotypes;
iii. counting a number of representative alleles on each maternal haplotype to determine a representation of the two maternal haplotypes;
iv. comparing the representation of the two maternal haplotypes to obtain a relative representation;
v. determining an over-representation ε of one of the two maternal haplotypes in the maternal sample containing DNA from the pregnant female and the fetus; and
vi. correlating said over-representation ε with a maternally inherited haplotype.
2. The method of claim 1 , wherein the relative representation of haplotypes is measured by digitally counting markers, wherein the markers are alleles that define each of the parental haplotypes.
3. The method of claim 2 , wherein sums of the count of markers specific to each of two maternal haplotypes within a haplotype block are compared to determine which maternal haplotype is over-represented.
4. The method of claim 2 , wherein sums of the count of markers specific to each of two paternal haplotypes within a haplotype block are compared to determine which paternal haplotype is over-represented.
5. The method of claim 2 , wherein the digital counting is performed by measuring numbers of counts of single DNA molecules.
6. The method of claim 5 , wherein the measuring is by sequencing, digital polymerase chain reaction (PCR) or hybridization.
7. The method of claim 1 , wherein a portion of the fetal genome is determined.
8. The method of claim 7 , wherein the entire fetal genome is determined.
9. A method of estimating the fraction of fetal DNA present in a maternal sample containing DNA from a pregnant female and a fetus by measuring the relative representation of the parental haplotypes according to claim 1 .
10. A method of non-invasively determining maternal haplotypes which are inherited by a fetus, comprising:
a. obtaining a maternal sample from a female pregnant with at least one fetus, wherein said sample contains DNA from both the pregnant female and the fetus;
b. counting markers in said sample that define each of two maternal haplotypes to determine a representation of the two haplotypes, comprising selecting markers that define two maternal haplotypes by simultaneously isolating all of the chromosomes from a single metaphase cell of the fetus's mother by partitioning said chromosomes into a plurality of channels of a microfluidic device;
c. comparing the representation of the two maternal haplotypes in the maternal sample containing DNA from the pregnant female and the fetus to obtain a relative representation;
d. determining an over-representation ε of one of the two haplotypes in the maternal sample containing DNA from the pregnant female and the fetus; and
e. correlating said over-representation ε with an inherited maternal haplotype.
11. The method of claim 10 , wherein the relative representation of haplotypes is measured by digitally counting markers, wherein the markers are alleles that define each of the maternal haplotypes.
12. The method of claim 11 , wherein sums of the count of markers specific to each of two maternal haplotypes within a haplotype block are compared to determine which maternal haplotype is over-represented.
13. The method of claim 11 , wherein the digital counting is performed by measuring numbers of counts of single DNA molecules carrying specific markers.
14. The method of claim 13 , wherein the measuring is by sequencing, digital polymerase chain reaction (PCR) or hybridization.
15. The method of claim 10 , wherein a portion of the fetal genome is determined.
16. The method of claim 15 , wherein the entire fetal genome is determined.
17. The method of claim 10 , further comprising non-invasively reconstructing the paternally inherited haplotypes.
18. The method of claim 17 , wherein the reconstruction of the paternally inherited haplotypes is achieved by haplotype imputations using paternal-specific alleles detected in the sample.